| 1 | 1433335 | ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. | J Natl Cancer Inst | 1992 Oct 7 |
2 |
| 2 | 1945841 | Induction of a mutant phenotype in human repair proficient cells after overexpression of a mutated human DNA repair gene. | Nucleic Acids Res | 1991 Oct 25 |
1 |
| 3 | 1956789 | Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. | Nucleic Acids Res | 1991 Nov 25 |
2 |
| 4 | 2005641 | Increased DNA synthesis and repair-enzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards. | J Natl Cancer Inst | 1991 Apr 17 |
1 |
| 5 | 2420469 | Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. | Cell | 1986 Mar 28 |
2 |
| 6 | 2918869 | The cloned human DNA excision repair gene ERCC-1 fails to correct xeroderma pigmentosum complementation groups A through I. | Mutat Res | 1989 Mar |
3 |
| 7 | 3347205 | Transfection of the cloned human excision repair gene ERCC-1 to UV-sensitive CHO mutants only corrects the repair defect in complementation group-2 mutants. | Mutat Res | 1988 Mar |
3 |
| 8 | 3931911 | A bioassay to measure cytotoxicity of plasma from patients treated with mitomycin C. | Cancer Res | 1985 Nov |
1 |
| 9 | 7404270 | A screening method for isolating DNA repair-deficient mutants of CHO cells. | Somatic Cell Genet | 1980 May |
2 |
| 10 | 7554089 | Repair of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea-induced damage by mammalian cell extracts. | Carcinogenesis | 1995 Sep |
1 |
| 11 | 7598728 | Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein. | Biochem Biophys Res Commun | 1995 Jun 26 |
1 |
| 12 | 7657672 | Human DNA repair excision nuclease. Analysis of the roles of the subunits involved in dual incisions by using anti-XPG and anti-ERCC1 antibodies. | J Biol Chem | 1995 Sep 1 |
1 |
| 13 | 7794804 | Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. | Cell Growth Differ | 1995 Apr |
2 |
| 14 | 7891694 | Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair. | Mol Cell Biol | 1995 Apr |
2 |
| 15 | 7923602 | Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity. | Carcinogenesis | 1994 Sep |
2 |
| 16 | 8040325 | Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. | J Clin Invest | 1994 Aug |
3 |
| 17 | 8065913 | Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage. | Nucleic Acids Res | 1994 Aug 11 |
2 |
| 18 | 8222071 | Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3. | Carcinogenesis | 1993 Oct |
1 |
| 19 | 9268987 | Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line. | Oncol Res | 1997 |
5 |
| 20 | 9360634 | A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. | Mutat Res | 1997 Sep |
2 |
| 21 | 9426281 | ASE-1: a novel protein of the fibrillar centres of the nucleolus and nucleolus organizer region of mitotic chromosomes. | Chromosoma | 1997 Dec |
1 |
| 22 | 9440758 | ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. | J Clin Oncol | 1998 Jan |
3 |
| 23 | 9703867 | Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line. | Anticancer Res | 1998 Jul-Aug |
6 |
| 24 | 9722577 | Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells. | J Biol Chem | 1998 Sep 4 |
3 |
| 25 | 9772291 | Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells. | Int J Oncol | 1998 Nov |
7 |
| 26 | 9852275 | Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines. | Int J Mol Med | 1998 Mar |
1 |
| 27 | 9861196 | Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. | Cancer Treat Rev | 1998 Oct |
1 |
| 28 | 9862190 | Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression. | Mutagenesis | 1998 Nov |
2 |
| 29 | 9933022 | Modulation of excision repair cross complementation group 1 (ERCC-1) mRNA expression by pharmacological agents in human ovarian carcinoma cells. | Biochem Pharmacol | 1999 Feb 15 |
10 |
| 30 | 10200525 | Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion. | Cell Death Differ | 1998 Aug |
1 |
| 31 | 10228559 | Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells. | Cell Mol Life Sci | 1999 Mar |
9 |
| 32 | 10493501 | Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins. | Cancer Res | 1999 Sep 15 |
3 |
| 33 | 10675489 | Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene. | Int J Oncol | 2000 Mar |
1 |
| 34 | 10741696 | Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair. | Clin Cancer Res | 2000 Mar |
4 |
| 35 | 10810335 | Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. | Anticancer Res | 2000 Mar-Apr |
10 |
| 36 | 10952103 | Association of an ERCC1 polymorphism with adult-onset glioma. | Cancer Epidemiol Biomarkers Prev | 2000 Aug |
2 |
| 37 | 11008124 | Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. | Biochem Pharmacol | 2000 Nov 1 |
3 |
| 38 | 11008128 | Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors. | Biochem Pharmacol | 2000 Nov 1 |
1 |
| 39 | 11008208 | ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells. | Int J Cancer | 2000 Sep 20 |
6 |
| 40 | 11077043 | Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues. | Biochem Pharmacol | 2000 Dec 1 |
4 |
| 41 | 11163512 | An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin. | Int J Radiat Oncol Biol Phys | 2001 Jan 1 |
5 |
| 42 | 11212280 | A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin. | Cancer Res | 2001 Jan 15 |
1 |
| 43 | 11589365 | Proteasome inhibition suppresses cisplatin-dependent ERCC-1 mRNA expression in human ovarian tumor cells. | Res Commun Mol Pathol Pharmacol | 2000 May-Jun |
6 |
| 44 | 11605182 | Predicting response to paclitaxel/carboplatin-based therapy in non-small cell lung cancer. | Semin Oncol | 2001 Aug |
1 |
| 45 | 11731512 | ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. | J Clin Oncol | 2001 Dec 1 |
5 |
| 46 | 11761458 | In vitro studies on the mechanisms of oxaliplatin resistance. | Cancer Chemother Pharmacol | 2001 Nov |
1 |
| 47 | 11936875 | Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression. | Cell Mol Biol (Noisy-le-grand) | 2001 |
2 |
| 48 | 11953324 | The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif. | EMBO J | 2002 Apr 15 |
1 |
| 49 | 12023789 | Pemetrexed combination therapy in the treatment of non-small cell lung cancer. | Semin Oncol | 2002 Apr |
1 |
| 50 | 12114432 | Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. | Clin Cancer Res | 2002 Jul |
14 |